Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum EU Taxonomy Data Preview
In 2024, Swedish Orphan Biovitrum was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.
The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.
Swedish Orphan Biovitrum has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Swedish Orphan Biovitrum are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Taxonomy Aligned A1 Turnover | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Taxonomy Eligible A Turnover | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Taxonomy Non-Eligible B Turnover | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | Copy restricted. Please purchase to unlock this data.  c | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Taxonomy Aligned A1 Opex | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Taxonomy Eligible A Opex | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. b | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Taxonomy Non-Eligible B Opex | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. b | Copy restricted. Please purchase to unlock this data. c | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Taxonomy Aligned A1 Capex | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data.  c | 0000000 |
Total Taxonomy Eligible A Capex | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | Copy restricted. Please purchase to unlock this data.  c | 0000000 |
Total Taxonomy Non-Eligible B Capex | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | Copy restricted. Please purchase to unlock this data.  c | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind Swedish Orphan Biovitrum’s EU Taxonomy Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Swedish Orphan Biovitrum’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into Swedish Orphan Biovitrum's Revenues from Sustainable Activities
In 2024, Swedish Orphan Biovitrum reported EU Taxonomy-eligible revenues of SEK 10.97 billion, representing 42% of its total turnover. Of this amount, SEK 0 of Swedish Orphan Biovitrum's revenues was classified as EU Taxonomy-aligned, indicating that 0% of the revenue-generating activities undertaken by the company substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS). a
Insights into Swedish Orphan Biovitrum's CAPEX from Sustainable Activities
In 2024, Swedish Orphan Biovitrum reported EU Taxonomy-eligible CAPEX of SEK 381.00 million, representing 67% of its total CAPEX. Of this amount, SEK 0 of Swedish Orphan Biovitrum's CAPEX was classified as EU Taxonomy-aligned, indicating that 0% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS). a
Swedish Orphan Biovitrum's Taxonomy-Eligible Capex Over Time
- Total Taxonomy Aligned A1 Capex
- Total Taxonomy Eligible but Not Aligned A2 Capex
Have Swedish Orphan Biovitrum's increased its investment in sustainable activities over time?
Since 2022, Swedish Orphan Biovitrum's taxonomy-aligned capital expenditure (CAPEX) decreased by 100%, indicating a long-term decline in green capital deployment, potentially signaling shifting priorities or reduced focus on sustainability-linked investments. a c
Insights into Swedish Orphan Biovitrum's OPEX from Sustainable Activities
In 2024, Swedish Orphan Biovitrum reported EU Taxonomy-eligible OPEX of SEK 1.24 billion, representing 35% of its total operating expenses (OPEX). Of this amount, SEK 0 of Swedish Orphan Biovitrum's OPEX was classified as EU Taxonomy-aligned, indicating that 0% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS). a